CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $146K of Crinetics Pharmaceuticals, Inc.
Sold$145,650
$48.55Price
3,000Shares
−4%Stake
What CRNX did after the filing
- The stock from Fri, Jul 12 close, $53.67
- −1.0%
- S&P 500, same days
- +0.4%
Measured over 30 trading days, to the Aug 23 close.
Traded Wed, Jul 10. Filed Fri, Jul 12, 12:30 PM ET, during the session. Returns use the Jul 12 close and the Aug 23 close. Not investment advice.